VERACYTE, INC. (VCYT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q3 '16: 60.9M Q4 '16: 65.1M Q1 '17: 68M Q2 '17: 71.7M Q3 '17: 70.6M Q4 '17: 72M Q1 '18: 75.6M Q2 '18: 79.9M Q3 '18: 85.9M Q4 '18: 92M Q1 '19: 101.5M Q2 '19: 108.9M Q3 '19: 116.4M Q4 '19: 120.4M Q1 '20: 122M Q2 '20: 112.5M Q3 '20: 112.7M Q4 '20: 117.5M Q1 '21: 123.1M Q2 '21: 157.5M Q3 '21: 186.7M Q4 '21: 219.5M Q1 '22: 250.6M Q2 '22: 268.4M Q3 '22: 283.6M Q4 '22: 296.5M Q1 '23: 311.2M Q2 '23: 328.6M Q3 '23: 343.1M Q4 '23: 361.1M Q1 '24: 375.5M Q2 '24: 399.6M Q3 '24: 425.3M Q4 '24: 445.8M Q1 '25: 463.4M Q2 '25: 479.1M Q3 '25: 495.1M Q4 '25: 517.1M Q1 '26: 541.7M Q2 '26: 561.9M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q4 '23: 229.7M Q1 '24: 240.8M Q2 '24: 262.9M Q3 '24: 284.2M Q4 '24: 298.1M Q1 '25: 315.2M Q2 '25: 327M Q3 '25: 339.3M Q4 '25: 362.5M Q1 '26: 384.2M Q2 '26: 403M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '16: -33.1M Q4 '16: -28.8M Q1 '17: -26.6M Q2 '17: -22.7M Q3 '17: -24.2M Q4 '17: -26.5M Q1 '18: -28M Q2 '18: -27.3M Q3 '18: -25.2M Q4 '18: -22.2M Q1 '19: -15.3M Q2 '19: -12.5M Q3 '19: -10M Q4 '19: -15.1M Q1 '20: -25.3M Q2 '20: -33.2M Q3 '20: -35.5M Q4 '20: -35.4M Q1 '21: -68.6M Q2 '21: -65M Q3 '21: -77.6M Q4 '21: -81.9M Q1 '22: -51.7M Q2 '22: -55M Q3 '22: -48M Q4 '22: -41.1M Q1 '23: -36.3M Q2 '23: -33.6M Q3 '23: -55.7M Q4 '23: -85.8M Q1 '24: -80M Q2 '24: -67.3M Q3 '24: -23.5M Q4 '24: 16.1M Q1 '25: 23.7M Q2 '25: 13.8M Q3 '25: 24.8M Q4 '25: 57.8M Q1 '26: 77.5M Q2 '26: 105.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

-80M -40M 0 40M 80M 120M Q3 '16: -35M Q4 '16: -31.4M Q1 '17: -29.5M Q2 '17: -25.6M Q3 '17: -27M Q4 '17: -31M Q1 '18: -29M Q2 '18: -28M Q3 '18: -25.4M Q4 '18: -20.1M Q1 '19: -15.7M Q2 '19: -12M Q3 '19: -8.2M Q4 '19: -12.6M Q1 '20: -22.4M Q2 '20: -30.9M Q3 '20: -34.3M Q4 '20: -34.9M Q1 '21: -65.1M Q2 '21: -63.1M Q3 '21: -73.1M Q4 '21: -75.6M Q1 '22: -48.2M Q2 '22: -48.6M Q3 '22: -43.2M Q4 '22: -36.6M Q1 '23: -30.2M Q2 '23: -29.1M Q3 '23: -50M Q4 '23: -74.4M Q1 '24: -68.2M Q2 '24: -54M Q3 '24: -9.3M Q4 '24: 24.1M Q1 '25: 33M Q2 '25: 26.3M Q3 '25: 30.3M Q4 '25: 66.4M Q1 '26: 88M Q2 '26: 114.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 15M 30M 45M Q2 '13: 10.6M Q3 '13: 11.7M Q4 '13: 12.6M Q1 '14: 13.4M Q2 '14: 14.2M Q3 '14: 15.2M Q4 '14: 16.6M Q1 '15: 17.6M Q2 '15: 18.7M Q3 '15: 20.2M Q4 '15: 21.5M Q1 '16: 23.2M Q2 '16: 24.4M Q3 '16: 25.1M Q4 '16: 25.5M Q1 '17: 25.5M Q2 '17: 26.1M Q3 '17: 26.9M Q4 '17: 28.2M Q1 '18: 29.8M Q2 '18: 31.1M Q3 '18: 32.1M Q4 '18: 33.1M Q1 '19: 33.7M Q2 '19: 34.3M Q3 '19: 35.1M Q4 '19: 36.1M Q4 '13 Q4 '14 Q4 '15 Q4 '16 Q4 '17 Q4 '18 Q4 '19

Operating Cash Flow TTM

-70M 0 70M 140M 210M Q3 '15: -32.6M Q4 '15: -27M Q1 '16: -26.7M Q2 '16: -22.9M Q3 '16: -26.6M Q4 '16: -28M Q1 '17: -27.5M Q2 '17: -24.7M Q3 '17: -22.3M Q4 '17: -23.9M Q1 '18: -23.2M Q2 '18: -21.4M Q3 '18: -18.1M Q4 '18: -13.5M Q1 '19: -7.1M Q2 '19: -6.5M Q3 '19: -6.2M Q4 '19: -3.2M Q1 '20: -7.5M Q2 '20: -13.5M Q3 '20: -10.2M Q4 '20: -9.7M Q1 '21: -45M Q2 '21: -34.7M Q3 '21: -37.8M Q4 '22: 7.5M Q1 '23: 14.2M Q2 '23: 31.3M Q3 '23: 38.4M Q4 '23: 44.2M Q1 '24: 37.4M Q2 '24: 50.3M Q3 '24: 66.1M Q4 '24: 75.1M Q1 '25: 89.4M Q2 '25: 93.5M Q3 '25: 108.2M Q4 '25: 136.3M Q1 '26: 166.2M Q2 '26: 178.4M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-60M 0 60M 120M 180M Q3 '15: -35.1M Q4 '15: -33.1M Q1 '16: -35.2M Q2 '16: -31.8M Q3 '16: -34.5M Q4 '16: -32.2M Q1 '17: -29.4M Q2 '17: -26M Q3 '17: -24.2M Q4 '17: -25.7M Q1 '18: -24.6M Q2 '18: -23.2M Q3 '18: -19.8M Q4 '18: -15.4M Q1 '19: -9.5M Q2 '19: -9M Q3 '19: -8.4M Q4 '19: -6M Q1 '20: -10.2M Q2 '20: -16.1M Q3 '20: -13.2M Q4 '20: -12.5M Q1 '21: -48.3M Q2 '21: -38.9M Q3 '21: -43.2M Q4 '22: -1M Q1 '23: 7.1M Q2 '23: 23M Q3 '23: 29.1M Q4 '23: 34.3M Q1 '24: 26.3M Q2 '24: 40.1M Q3 '24: 56.5M Q4 '24: 63.8M Q1 '25: 78.5M Q2 '25: 84M Q3 '25: 98.2M Q4 '25: 126.6M Q1 '26: 155.3M Q2 '26: 166M Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q2 '20: 50.2M Q3 '20: 54.9M Q1 '21: 63.3M Q2 '21: 67.3M Q3 '21: 69.7M Q1 '22: 71.2M Q2 '22: 71.5M Q3 '22: 71.7M Q1 '23: 72.2M Q2 '23: 72.5M Q3 '23: 72.8M Q1 '24: 74.8M Q2 '24: 77.2M Q3 '24: 78.5M Q1 '25: 80.1M Q2 '25: 78.4M Q3 '25: 79.7M Q1 '26: 81.3M Q2 '26: 82.1M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50 Q3 '16: -1.25 Q4 '16: -1.10 Q1 '17: -0.98 Q2 '17: -0.80 Q3 '17: -0.81 Q4 '17: -0.91 Q1 '18: -0.94 Q2 '18: -0.90 Q3 '18: -0.81 Q4 '18: -0.65 Q1 '19: -0.43 Q2 '19: -0.30 Q3 '19: -0.20 Q4 '19: -0.27 Q1 '20: -0.46 Q2 '20: -0.63 Q3 '20: -0.69 Q4 '20: -0.68 Q1 '21: -1.10 Q2 '21: -1.01 Q3 '21: -1.13 Q4 '21: -1.13 Q1 '22: -0.67 Q2 '22: -0.67 Q3 '22: -0.59 Q4 '22: -0.50 Q1 '23: -0.41 Q2 '23: -0.40 Q3 '23: -0.69 Q4 '23: -1.02 Q1 '24: -0.93 Q2 '24: -0.74 Q3 '24: -0.14 Q4 '24: 0.30 Q1 '25: 0.41 Q2 '25: 0.33 Q3 '25: 0.38 Q4 '25: 0.82 Q1 '26: 1.08 Q2 '26: 1.40 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.